Deep-dive AI research reports on individual stocks, powered by our proprietary signals. Every report carries a direction (Bullish or Bearish) and a conviction level(Strong or Speculative). We track stock performance since each report's publication date — because we believe great analysis should be held accountable.

The Asymmetric Trap Hidden in Mirum Pharmaceuticals (MIRM)

2026-04-28BullishStrongChange from report: +2.7%

Mirum Pharma (MIRM) shows explosive revenue growth and strong cash, yet has 20% short interest. Major funds are accumulating while retail bets on puts, creating a high-tension setup ahead of key positive trial data.